Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07114718) titled 'Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study' on Aug. 3.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Starlight Cardiovascular Inc

Condition: Congenital Heart Disease Congenital Heart Disease (CHD)

Intervention: Device: Ductus Arteriosus Stent

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 2025

Target Sample Size: 35

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07114718

Published by HT Digital Content Se...